Plaintiff
Defendant
- Parties: The plaintiffs were Janssen Inc and Actelion Pharmaceuticals Ltd. The defendant was Sandoz Canda Inc.
- Subject Matter: This was an action under the Patented Medicines (NOC) Regulations.
- Date: The hearing was set on Feb. 1, 2024.
- Venue: This was a federal case before the Federal Court.
- Amount: No financial award was specified.
Court
Federal CourtCase Number
T-1287-23Practice Area
Intellectual propertyAmount
Winner
Trial Start Date
21 June 2023Download documents